阻断CD47通过CD103+树突状细胞-NK细胞轴促进小鼠肝细胞癌模型的抗肿瘤免疫
本研究探讨CD47阻断后肝细胞癌微环境中树突状细胞与自然杀伤细胞的关系。在人及小鼠肝细胞癌标本中分析CD103+树突状细胞与NK细胞浸润,并用原位肝肿瘤模型评估CD47阻断后CD103+树突状细胞-NK细胞轴功能。结果显示CD47高表达与患者预后较差相关,CD47阻断通过cGAS-STING通路激活CD103+树突状细胞并招募活化NK细胞发挥抗肿瘤作用。
要点
- CD47高表达与肝细胞癌患者预后较差相关。
- CD47阻断通过CD103+树突状细胞-NK细胞轴增强抗肿瘤疗效。
- 缺氧微环境促进CD47阻断诱导的CD103+树突状细胞对肿瘤DNA的吞噬。
核心结论
- 除经典的树突状细胞-T细胞轴外,CD47阻断显著增强CD103+树突状细胞摄取肿瘤DNA的能力,激活cGAS-STING通路,促进NK细胞在肝癌中的浸润与活化。
研究设计与样本
- 研究采用人及小鼠肝细胞癌标本进行免疫组化和免疫荧光分析,并使用原位肝肿瘤模型在野生型、Rag1-/-、Batf3-/-和STING1-/-小鼠中评估CD47阻断后CD103+树突状细胞-NK细胞轴的功能。
主要发现
- CD47高表达与肝细胞癌患者预后较差相关。
- CD47阻断通过刺激CD103+树突状细胞-NK细胞轴增强抗肿瘤疗效。
- 缺氧微环境促进CD47阻断诱导的CD103+树突状细胞对肿瘤DNA的吞噬。
- 活化的CD103+树突状细胞释放IL-12和CXCL9,诱导NK细胞招募并上调颗粒酶B、NKG2D、干扰素-γ和肿瘤坏死因子-α表达,下调NKG2A表达。
- CD47阻断的抗肿瘤效应可被环鸟苷酸-腺苷酸合成酶(cGAS)-STING通路抑制所消除。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The CD47-signal regulatory protein α (SIRPα) axis inhibits dendritic cell (DC) phagocytosis and contributes to immune evasion. However, the behaviour of DCs and the potential crosstalk between DCs and natural killer (NK) cells in the hepatocellular carcinoma (HCC) microenvironment after CD47 blockade remain unclear. METHODS: The infiltration of CD103+ DCs and NK cells were analysed by immunohistochemistry and immunofluorescence in both human and murine HCC specimens. An orthotopic liver tumour model was used to evaluate the function of the CD103+ DC-NK cell axis after CD47 blockade in vivo in wild-type, Rag1-/-, Batf3-/-, and STING1-/- mice. Phagocytosis assays were performed in CD103+ DC and HCC cell lines. CD103+ DC-derived cytokines were analysed by chemokine array. Spleen-derived NK cells in C57BL/6J mice were used to evaluate cytotoxic functions in vitro. RESULTS: Higher CD47 expression was associated with worse prognosis in patients with HCC. CD47 blockade enhanced antitumour efficacy by stimulating the CD103+ DC-NK cell axis. The hypoxic microenvironment promoted CD47 blockade-induced tumour DNA phagocytosis by CD103+ DCs. By releasing IL-12 and CXCL9, activated CD103+ DCs induced the recruitment of NK cells with upregulated expression of granzyme B, NKG2D, interferon-γ, and tumour necrosis factor-α and downregulated expression of NKG2A. The antitumour effects of CD47 blockade could be abolished by cyclic GMP-AMP synthase (cGAS)-STING pathway inhibition. CONCLUSIONS: In addition to the classical DC-T cell axis, CD47 blockade significantly enhanced the ability of CD103+ DCs to take up tumour DNA, resulting in the stimulation of the cGAS-STING pathway, which promoted the infiltration and activation of NK cells in liver cancer. LAY SUMMARY: Hypoxia (low oxygen levels) is prevalent in the hepatocellular carcinoma microenvironment and promotes the phagocytosis (ingestion and elimination) of tumour DNA by CD103+ dendritic cells (a type of immune cell). Blockade of the cell surface protein CD47 resulted in activation of CD103+ dendritic cells which led to the recruitment and activation of natural killer cells (a different immune cell). When activated, these cells exhibit an antitumour effect.
引用
- Wang S, Wu Q, Chen T, et al. Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell-NK cell axis in murine hepatocellular carcinoma model. J Hepatol. 2022. PMID: 35367532. doi:10.1016/j.jhep.2022.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。